Skip to content 
| Metric | Value |
| Number of companies that went public | 197 |
| Notable companies that went public | Kairos Pharma, Alumis, Contineum Therapeutics, Chromocell Therapeutics, Metagenomi |
| Number of companies that have been acquired | 5 |
| Total IPOs globally in first half of 2024 | 551 (raising $52 billion) |
| Notable upcoming IPOs | Databricks, Chime, BMC Software |
| Key industries for IPOs | Biotechnology, Technology |
| Overall IPO market trend | Active, with mixed results and cautious optimism |
Going public is a big step for any company. It opens up opportunities for them to connect with more everyday folks and let more people feel like they have a stake in the story. In 2024, we saw some businesses take that leap for the first time by offering shares for sale on the stock market. Reports showed it was a busy time for initial public offerings (IPOs), especially for new companies in biotech and tech just starting out.
These IPOs created a chance for folks like you and me to get in on the ground floor supporting growing companies close to home. For those looking for the basic info on who decided to welcome more people as partners in their success, here’s a quick lowdown on some of the notable things that went down in the markets in 2024 without bogging you down with unnecessary details.
A Quick Rundown of What Was Happening In the Markets in 2024
Lots was changing in the 2024 global economy that impacted trading day to day. (1)
Here’s our compiled breakdown:
Global economic bounce-back
The worldwide situation started turning itself around in early 2024 after slowing down in some places before that. Because of this good news, stock prices went up around 10% as investors started feeling more hopeful about the future again.
Interest rate cuts by the Fed
In March, the decision was made to lower interest rates for the first time since they’d gone up. Markets reacted positively since falling prices and slower growth meant the expected rate cuts everyone was waiting on were coming soon. Investors were hoping the US economy could make a soft landing.
Ongoing conflicts created uncertainty
Ongoing troubles like the conflict between Russia and Ukraine, as well as tensions in the Middle East, left some uncertainty. While early 2024 saw potential for improvements, worries about oil prices due to these situations possibly worsening still lingered.
Upcoming US elections added questions
As the presidential vote in November neared, political developments got close watch. Markets wanted to know how outcomes might affect economic and money policies.
A rough August for stocks
Disappointing company reports, especially from tech giants, caused major indexes to drop over 6% and nearly 8%. Investors feared a coming recession.
Different central bank moves worldwide
While many non-US banks eased policies, the Fed stayed cautious. This led currencies and international stocks to change in value.
Falling inflation boosted optimism
Much lower prices globally, particularly heading back to targets in Europe, fostered hopes for stability and growth.
Initial gains and later volatility showed how fragile confidence was with ongoing global challenges. As the year went on, focus stayed on how these factors might develop further.
Key Information You Should Know in 2024
Credits: Bloomberg Technology
Many interesting things happened with companies going public, known as IPOs, in 2024. (2)
Here are some important points:
Tech and healthcare led the way
These industries drove most IPO activity due to fast innovations and high interest from investors. Companies in artificial intelligence and biotech like Klarna, Discord, and Databricks prepared to launch public offerings later in 2024.
Industrial sector saw growth too
In the second quarter alone, 17 new industrial listings raised $2.25 billion total. This shows investors liked stable industries.
More companies filed for IPOs
By mid-year, 107 filings occurred in the US, beating all of 2023. This bounce-back came after past economic slowdowns. Globally, the first half saw 551 IPOs raise $52 billion, a small rise from previous periods.
Cross-border listings grew popular
Major American IPOs like Lineage and Tempus AI targeted different investor groups through this strategy. It reflected efforts to tap global financial markets.
Interest rates and economy shaped behavior
As rate cuts seemed likely later in 2024 due to stable prices, confidence picked up to help IPO conditions. Steady 2.6% global growth also reassured investors.
Mixed results and some caution remained
While large firms achieved good prices and returns, consumer retail struggled with major declines. Healthcare did moderately well but faced challenges too. Political tensions and elections added worries.
In summary, IPO activity rebounded across key industries and filings increased despite past hurdles. However, external risks ensured a degree of care among market participants for the rest of the year.
Notable IPOs in 2024
1. Kairos Pharma
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Biotechnology
- IPO Price: $4.00
- IPO Date: September 16, 2024
Kairos Pharma’s debut on the stock market in September got folks buzzing, but it’s been a bumpy ride since. The oncology-focused company raised $6.2 million at an IPO price of $4 per share.
While the funds will support Kairos’ promising pipeline of potential new treatments, which aims to tackle tough cancer issues like suppressed immune systems and drugs stopping working, investors have voiced doubts so far. The stock now trades around $1.36, showing it’s been hard meeting expectations.
Developing breakthrough treatments is no easy task. It’ll take time for Kairos’ research to start paying off as therapies are tested in studies. If the company can demonstrate progress toward its goals, shareholders may feel more optimistic again. Cancer research is a marathon, not a sprint.
For now, Kairos remains in the starting blocks publicly. But its work trying to understand how cancer operates keeps it a name worth watching in biotech. As the pipeline moves along, there’s hope share prices will bounce back to reflect the potential to transform outcomes for patients. Success could restore investor faith that the long road ahead may lead somewhere good.
2. Alumis
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Biotechnology
- IPO Price: $16.00
- IPO Date: June 27, 2024
Alumis launched its IPO on June 27th, 2024, setting the initial stock price at $16. The company is focused on developing treatments for conditions that affect people’s immune systems. The money raised from going public will help support their ongoing clinical trials as they work to move projects forward.
Currently, the stock price is trading at $10.03. This drop shows the market is still figuring out what Alumis is really worth. Their focus on immune diseases is important though – lots of folks deal with these issues, so there’s definitely a need for new and effective treatments. Alumis aims to fill that need. Investors will be watching to see how the company’s research progresses, hoping the stock price rebounds as they advance their work. Overall, Alumis is another important player in the biotech field working to help people.
3. Contineum Therapeutics
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Biotechnology
- IPO Price: $16.00
- IPO Date: April 4, 2024
Contineum Therapeutics launched its IPO on April 4th, 2024, with the starting stock price set at $16. The company is focused on developing oral pills aimed at treating conditions related to neuroscience and the immune system. Their goal is to create meds that can effectively handle complex health issues.
Since going public, Contineum’s stock has been doing well. The current price is $17.63, showing an upward trend so far. Investors seem to like the company’s innovative approach. The potential for their therapies to make a real difference in patient care is big. Contineum’s work in neuro and immunology could lead to new treatments that improve lives. As they continue researching and developing, many will be watching to see how the company progresses and if it can keep the growth going.
4. Chromocell Therapeutics
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Biotechnology
- IPO Price: $6.00
- IPO Date: February 15, 2024
Chromocell Therapeutics had its IPO on February 15, 2024, with the starting stock price at $6. The company’s mission is to develop non-opioid medications for pain relief. This focus is important, given valid worries about opioid use and addiction issues.
Unfortunately, Chromocell’s stock has faced challenges since launching. It’s currently trading at $0.68, a big drop from its initial price. This decline signals investors may have doubts about the company’s ability to achieve what it set out to do.
Despite hitting a snag, the need for safe and effective pain solutions means Chromocell remains in the spotlight. Many folks are hopeful the company can turn things around as it works on developing its products. The road ahead may be bumpy, but Chromocell’s focus on pain relief is still crucial in today’s healthcare landscape.
5. Metagenomi
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Biotechnology
- IPO Price: $15.00
- IPO Date: February 8, 2024
Metagenomi went public on February 8, 2024, with the initial stock price set at $15. The company focuses on precision genetic medicines, which aim to treat diseases by targeting their genetic roots. Their work in metagenomics allows them to study the DNA from various organisms to find new ways to tackle health issues.
Since going public, Metagenomi has faced difficulties. The current stock price is $2.05, a big drop from its original value. Investors may doubt the company’s ability to successfully develop effective products.
Despite the challenges, the field of genetic medicine remains promising. Metagenomi’s approach of using genetic information could lead to innovative new treatments. Many are hopeful the company can recover and make meaningful contributions to healthcare. Their focus on precision medicine is important as the industry keeps seeking better solutions for complex diseases.
6. Databricks (Upcoming)
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Technology (Cloud Computing)
- IPO Price: Not Available
- IPO Date: Late 2024 or Early 2025
Databricks is on the verge of going public, with plans for an IPO set for late 2024 or early 2025. The company specializes in a cloud-based data platform that uses artificial intelligence (AI) and machine learning. Their platform helps businesses manage and analyze huge amounts of info quickly and easily.
Databricks has become popular with companies looking to boost their data strategies. As data becomes more important in decision-making, demand keeps growing for tools like what Databricks offers. Investors are watching closely, as the IPO could present exciting chances. If all goes well, it may attract a lot of interest from both tech fans and investors.
7. Chime (Upcoming)
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Financial Technology
- IPO Price: Not Available
- IPO Date: 2024
Chime is a financial technology company planning to go public in 2024. The company aims to make banking more accessible, especially for lower-income Americans. Chime offers services like free checking accounts and debit cards, making it easier for people to manage their money without hidden fees.
By focusing on a customer-friendly approach, Chime has gained a loyal customer base. The company addresses issues like high fees commonly associated with traditional banks. As more people look for affordable banking options, Chime’s services are becoming increasingly popular. Investors are interested in how this IPO might perform, given the growing demand for fintech solutions that help regular folks.
8. BMC Software (Upcoming)
- Country: United States
- Stock Exchange: Nasdaq
- Industry: Software (IT Management)
- IPO Price: Not Available
- IPO Date: 2024
BMC Software has filed for an IPO and may launch in 2024, depending on how the market looks. The company provides software solutions for managing IT departments. Their products help businesses automate processes and handle their technology infrastructure more efficiently.
BMC Software has been around for a long time and is known for reliable services. As companies keep investing in technology, the need for effective IT solutions stays strong. Investors are curious about how BMC Software’s IPO might do. If the company can attract interest, it could see a successful launch and positive response in the market.
Conclusion
In 2024, several companies made their mark by going public, especially in biotech and tech. While some hit bumps, the overall IPO market stays active. Investors have exciting opportunities coming up, but they should keep up with market changes and how companies are doing.
FAQs
What tech companies and AI IPO candidates made headlines in the market today?
Tech IPOs dominated the 2024 landscape, with several tech companies going public. Companies like Reddit, which boasts a massive user base, and AI-focused firms like Astera Labs attracted attention. Many of these companies are based in San Francisco and leverage AI models in their operations.
How did interest rate changes affect the IPO window and market trends?
The IPO calendar in 2024 was heavily influenced by interest rate decisions. This affected when companies chose their IPO window, particularly in the second half of the year. Public market conditions and guidance from Goldman Sachs helped companies time their market entry.
What steps should investors take to buy IPO shares and common stock?
To participate in upcoming IPOs, investors typically work with third-party brokers. Yahoo Finance and stock exchange websites provide price range information and ticker symbol details. Companies usually announce their IPO proceeds and company plans before going public.
Which consumer-focused companies from a wide range of industries went public?
The year saw diverse offerings including Turo (car rental platform connecting car owners), Skims (clothing), Foods (consumer goods), and Liquid Death (beverages). SeatGeek and StubHub represented the entertainment sector.
How did tech stocks perform among the new public company listings?
Notable entries included Neo4j (open source database), Cohesity (data management), and CoreWeave (computing). Tech companies from the United States, especially those with strong supply chain networks and substantial funding round history, attracted investor attention.
What role did social media platforms play in the IPO market?
Reddit generated significant buzz due to its large social media presence. Companies leveraged their user base to attract potential investors. The public market showed particular interest in platforms with established market trends and growth potential.
Which financial technology firms pursued public market listings?
Klarna and Chime represented the digital banking sector, while Circle brought cryptocurrency expertise to the market. These companies often emphasized their tech stock potential and growth in the United States market.
What biotech and healthcare companies entered the stock exchange?
Healthcare offerings included Upstream Bio, Boundless Bio, and Cerebras. These companies typically highlighted their research capabilities and potential market impact during their funding round presentations.
How did companies perform on their first day of trading in the public markets?
Most companies saw significant price movements during their first day of trading. Market analysts closely watched these debuts to gauge investor confidence in different business models. The current market conditions in 2024 influenced initial performance, with some companies exceeding expectations.
What role did silicon valley play in the 2024 IPO landscape?
Silicon Valley continued to be a major source of IPOs, particularly from companies working with large language models and AI technology. These firms often chose between traditional IPOs and direct listing approaches based on their market strategy and revenue growth patterns.
How did companies demonstrate their business model strength before going public?
Companies focused on showcasing their revenue growth and market penetration before entering public markets. This was especially important given the current market conditions. Many presented detailed business models showing their path to profitability.
Which healthcare innovations attracted attention in the IPO market?
Healthcare technology companies like Fractyl Health brought innovative treatments to public markets. Their business models often combined medical advances with scalable technology platforms, attracting investors interested in healthcare innovation.
184 companies that went public in 2024
| IPO Date | Symbol | Company Name | Stock Exchange |
| Oct 25, 2024 | WRD | WeRide Inc. | NASDAQ |
| Oct 25, 2024 | SEPN | Septerna, Inc. | NASDAQ |
| Oct 24, 2024 | INGM | Ingram Micro Holding Corporation | NYSE |
| Oct 24, 2024 | BEAG | Bold Eagle Acquisition Corp. | NASDAQ |
| Oct 24, 2024 | OACC | Oaktree Acquisition Corp. III Life Sciences | NASDAQ |
| Oct 24, 2024 | CHAR | Charlton Aria Acquisition Corporation | NASDAQ |
| Oct 23, 2024 | LBGJ | Li Bang International Corporation Inc. | NASDAQ |
| Oct 23, 2024 | ROLR | High Roller Technologies, Inc. | NYSEAMERICAN |
| Oct 23, 2024 | FGL | Founder Group Limited | NASDAQ |
| Oct 23, 2024 | SAG | SAG Holdings Limited | NASDAQ |
| Oct 22, 2024 | ALDF | Aldel Financial II Inc. | NASDAQ |
| Oct 22, 2024 | HUHU | HUHUTECH International Group Inc. | NASDAQ |
| Oct 17, 2024 | ORIS | Oriental Rise Holdings Limited | NASDAQ |
| Oct 17, 2024 | SPHL | Springview Holdings Ltd | NASDAQ |
| Oct 16, 2024 | PTLE | PTL Limited | NASDAQ |
| Oct 15, 2024 | SFHG | Samfine Creation Holdings Group Limited | NASDAQ |
| Oct 11, 2024 | UPB | Upstream Bio, Inc. | NASDAQ |
| Oct 11, 2024 | CBLL | CeriBell, Inc. | NASDAQ |
| Oct 11, 2024 | CCIR | Cohen Circle Acquisition Corp. I | NASDAQ |
| Oct 11, 2024 | CAMP | Camp4 Therapeutics Corporation | NASDAQ |
| Oct 11, 2024 | RDAC | Rising Dragon Acquisition Corp. | NASDAQ |
| Oct 11, 2024 | STFS | Star Fashion Culture Holdings Limited | NASDAQ |
| Oct 9, 2024 | KLC | KinderCare Learning Companies, Inc. | NYSE |
| Oct 9, 2024 | CLIK | Click Holdings Limited | NASDAQ |
| Oct 8, 2024 | LPBB | Launch Two Acquisition Corp. | NASDAQ |
| Oct 8, 2024 | SKK | SKK Holdings Limited | NASDAQ |
| Oct 4, 2024 | FLX | BingEx Limited | NASDAQ |
| Oct 4, 2024 | CBNA | Chain Bridge Bancorp, Inc. | NYSE |
| Oct 2, 2024 | SARO | StandardAero, Inc. | NYSE |
| Oct 2, 2024 | FVR | FrontView REIT, Inc. | NYSE |
| Oct 2, 2024 | WCT | Wellchange Holdings Company Limited | NASDAQ |
| Oct 1, 2024 | HTLM | HomesToLife Ltd | NASDAQ |
| Sep 30, 2024 | ZJK | ZJK Industrial Co., Ltd. | NASDAQ |
| Sep 26, 2024 | BKV | BKV Corporation | NYSE |
| Sep 26, 2024 | GRDN | Guardian Pharmacy Services, Inc. | NYSE |
| Sep 26, 2024 | BIOA | BioAge Labs, Inc. | NASDAQ |
| Sep 26, 2024 | LGCY | Legacy Education Inc. | NYSEAMERICAN |
| Sep 26, 2024 | IBG | Innovation Beverage Group Limited | NASDAQ |
| Sep 25, 2024 | PC | Premium Catering (Holdings) Limited | NASDAQ |
| Sep 20, 2024 | GLE | Global Engine Group Holding Limited | NASDAQ |
| Sep 20, 2024 | CAPN | Cayson Acquisition Corp | NASDAQ |
| Sep 18, 2024 | YHNA | YHN Acquisition I Limited | NASDAQ |
| Sep 16, 2024 | IBO | Impact BioMedical Inc. | NYSEAMERICAN |
| Sep 16, 2024 | KAPA | Kairos Pharma, Ltd. | NYSEAMERICAN |
| Sep 13, 2024 | BCAX | Bicara Therapeutics Inc. | NASDAQ |
| Sep 13, 2024 | ZBIO | Zenas BioPharma, Inc. | NASDAQ |
| Sep 13, 2024 | MBX | MBX Biosciences, Inc. | NASDAQ |
| Sep 12, 2024 | GLXG | Galaxy Payroll Group Limited | NASDAQ |
| Sep 12, 2024 | FVN | Future Vision II Acquisition Corp. | NASDAQ |
| Sep 10, 2024 | XCH | XCHG Limited | NASDAQ |
| Sep 10, 2024 | TDTH | Trident Digital Tech Holdings Ltd | NASDAQ |
| Sep 6, 2024 | POLE | Andretti Acquisition Corp. II | NASDAQ |
| Sep 6, 2024 | VCIC | Vine Hill Capital Investment Corp. | NASDAQ |
| Sep 5, 2024 | PTHL | Pheton Holdings Ltd | NASDAQ |
| Sep 5, 2024 | PMAX | Powell Max Limited | NASDAQ |
| Aug 29, 2024 | GIG | GigCapital7 Corp. | NASDAQ |
| Aug 28, 2024 | BSII | Black Spade Acquisition II Co | NASDAQ |
| Aug 28, 2024 | AZI | Autozi Internet Technology (Global) Ltd. | NASDAQ |
| Aug 28, 2024 | SPAI | Safe Pro Group Inc. | NASDAQ |
| Aug 27, 2024 | JBDI | JBDI Holdings Limited | NASDAQ |
| Aug 23, 2024 | RITR | Reitar Logtech Holdings Limited | NASDAQ |
| Aug 23, 2024 | WOK | WORK Medical Technology Group LTD | NASDAQ |
| Aug 16, 2024 | HOND | HCM II Acquisition Corp. | NASDAQ |
| Aug 16, 2024 | SBXD | SilverBox Corp IV | NYSE |
| Aug 16, 2024 | YXT | YXT.COM Group Holding Limited | NASDAQ |
| Aug 13, 2024 | ACTU | Actuate Therapeutics, Inc. | NASDAQ |
| Aug 13, 2024 | CEP | Cantor Equity Partners, Inc. | NASDAQ |
| Aug 9, 2024 | VACH | Voyager Acquisition Corp. | NASDAQ |
| Aug 7, 2024 | EQV | EQV Ventures Acquisition Corp. | NYSE |
| Aug 1, 2024 | AAM | AA Mission Acquisition Corp. | NYSE |
| Aug 1, 2024 | MBAV | M3-Brigade Acquisition V Corp. | NASDAQ |
| Aug 1, 2024 | OSTX | OS Therapies Incorporated | NYSEAMERICAN |
| Jul 26, 2024 | NIPG | NIP Group Inc. | NASDAQ |
| Jul 25, 2024 | LINE | Lineage, Inc. | NASDAQ |
| Jul 25, 2024 | CON | Concentra Group Holdings Parent, Inc. | NYSE |
| Jul 25, 2024 | DTSQ | DT Cloud Star Acquisition Corporation | NASDAQ |
| Jul 25, 2024 | ORKT | Orangekloud Technology Inc. | NASDAQ |
| Jul 24, 2024 | OS | OneStream, Inc. | NASDAQ |
| Jul 24, 2024 | BLMZ | BloomZ Inc. | NASDAQ |
| Jul 23, 2024 | PGHL | Primega Group Holdings Limited | NASDAQ |
| Jul 19, 2024 | ARTV | Artiva Biotherapeutics, Inc. | NASDAQ |
| Jul 19, 2024 | QMMM | QMMM Holdings Limited | NASDAQ |
| Jul 18, 2024 | ARDT | Ardent Health Partners, Inc. | NYSE |
| Jul 18, 2024 | TWFG | TWFG, Inc. | NASDAQ |
| Jul 12, 2024 | LPAA | Launch One Acquisition Corp. | NASDAQ |
| Jul 12, 2024 | ICON | Icon Energy Corp. | NASDAQ |
| Jul 10, 2024 | SIMA | SIM Acquisition Corp. I | NASDAQ |
| July 2, 2024 | EURK | Eureka Acquisition Corp | NASDAQ |
| July 2, 2024 | EHGO | Eshallgo Inc. | NASDAQ |
| June 28, 2024 | LB | LandBridge Company LLC | NYSE |
| June 28, 2024 | ALMS | Alumis Inc. | NASDAQ |
| June 28, 2024 | LSH | Lakeside Holding Limited | NASDAQ |
| June 27, 2024 | WBTN | WEBTOON Entertainment Inc. | NASDAQ |
| June 27, 2024 | TBN | Tamboran Resources Corporation | NYSE |
| June 26, 2024 | GRAF | Graf Global Corp. | NYSEAMERICAN |
| June 21, 2024 | RECT | Rectitude Holdings Ltd | NASDAQ |
| Jun 18, 2024 | CUB | Lionheart Holdings | NASDAQ |
| Jun 18, 2024 | MACI | Melar Acquisition Corp. I | NASDAQ |
| Jun 18, 2024 | FSHP | Flag Ship Acquisition Corporation | NASDAQ |
| Jun 14, 2024 | TEM | Tempus AI, Inc | NASDAQ |
| Jun 12, 2024 | PCSC | Perceptive Capital Solutions Corp | NASDAQ |
| Jun 11, 2024 | ALF | Centurion Acquisition Corp. | NASDAQ |
| Jun 7, 2024 | WAY | Waystar Holding Corp. | NASDAQ |
| Jun 7, 2024 | RAPP | Rapport Therapeutics, Inc. | NASDAQ |
| Jun 7, 2024 | CHEB | Chenghe Acquisition II Co. | NYSEAMERICAN |
| Jun 6, 2024 | GAUZ | Gauzy Ltd. | NASDAQ |
| Jun 6, 2024 | FLYE | Fly-E Group, Inc. | NASDAQ |
| May 31, 2024 | KDLY | Kindly MD, Inc. | NASDAQ |
| May 23, 2024 | BOW | Bowhead Specialty Holdings Inc. | NYSE |
| May 17, 2024 | HDL | Super Hi International Holding Ltd. | NASDAQ |
| May 17, 2024 | RFAI | RF Acquisition Corp II | NASDAQ |
| May 15, 2024 | JDZG | JIADE Limited | NASDAQ |
| May 15, 2024 | RAY | Raytech Holding Limited | NASDAQ |
| May 14, 2024 | BTOC | Armlogi Holding Corp. | NASDAQ |
| May 10, 2024 | ZK | ZEEKR Intelligent Technology Holding Limited | NYSE |
| May 9, 2024 | GPAT | GP-Act III Acquisition Corp. | NASDAQ |
| May 9, 2024 | PAL | Proficient Auto Logistics, Inc. | NASDAQ |
| May 9, 2024 | SVCO | Silvaco Group, Inc. | NASDAQ |
| May 8, 2024 | NNE | NANO Nuclear Energy Inc. | NASDAQ |
| May 2, 2024 | CCIX | Churchill Capital Corp IX | NASDAQ |
| May 1, 2024 | VIK | Viking Holdings Ltd | NYSE |
| Apr 26, 2024 | ZONE | CleanCore Solutions, Inc. | NYSEAMERICAN |
| Apr 25, 2024 | LOAR | Loar Holdings Inc. | NYSE |
| Apr 25, 2024 | RBRK | Rubrik, Inc. | NYSE |
| Apr 25, 2024 | MRX | Marex Group plc | NASDAQ |
| Apr 23, 2024 | NCI | Neo-Concept International Group Holdings Limited | NASDAQ |
| Apr 22, 2024 | YYGH | YY Group Holding Limited | NASDAQ |
| Apr 22, 2024 | MFI | mF International Limited | NASDAQ |
| Apr 19, 2024 | TRSG | Tungray Technologies Inc. | NASDAQ |
| Apr 18, 2024 | IBTA | Ibotta, Inc. | NYSE |
| Apr 18, 2024 | CTRI | Centuri Holdings, Inc. | NYSE |
| Apr 18, 2024 | MTEN | Mingteng International Corporation Inc. | NASDAQ |
| Apr 18, 2024 | CDTG | CDT Environmental Technology Investment Holdings Limited | NASDAQ |
| Apr 17, 2024 | JUNE | Junee Limited | NASDAQ |
| Apr 16, 2024 | TWG | Top Wealth Group Holding Limited | NASDAQ |
| Apr 12, 2024 | ULS | UL Solutions Inc. | NYSE |
| Apr 11, 2024 | PACS | PACS Group, Inc. | NYSE |
| Apr 10, 2024 | MNDR | Mobile-health Network Solutions | NASDAQ |
| Apr 5, 2024 | CTNM | Contineum Therapeutics, Inc. | NASDAQ |
| Apr 2, 2024 | MAMO | Massimo Group | NASDAQ |
| Apr 2, 2024 | ZBAO | Zhibao Technology Inc. | NASDAQ |
| Mar 28, 2024 | BOLD | Boundless Bio, Inc. | NASDAQ |
| Mar 28, 2024 | MMA | Alta Global Group Limited | NYSEAMERICAN |
| Mar 28, 2024 | UBXG | U-BX Technology Ltd. | NASDAQ |
| Mar 26, 2024 | IBAC | IB Acquisition Corp. | NASDAQ |
| Mar 22, 2024 | AUNA | Auna S.A. | NYSE |
| Mar 21, 2024 | RDDT | Reddit, Inc. | NYSE |
| Mar 21, 2024 | BKHA | Black Hawk Acquisition Corporation | NASDAQ |
| Mar 21, 2024 | LOBO | Lobo EV Technologies Ltd. | NASDAQ |
| Mar 20, 2024 | ALAB | Astera Labs, Inc. | NASDAQ |
| Mar 20, 2024 | INTJ | Intelligent Group Limited | NASDAQ |
| Mar 6, 2024 | RYDE | Ryde Group Ltd | NYSEAMERICAN |
| Mar 5, 2024 | LGCL | Lucas GC Limited | NASDAQ |
| Feb 27, 2024 | SMXT | SolarMax Technology, Inc. | NASDAQ |
| Feb 22, 2024 | VHAI | Vocodia Holdings Corp | BATS |
| Feb 21, 2024 | DYCQ | DT Cloud Acquisition Corporation | NASDAQ |
| Feb 16, 2024 | CHRO | Chromocell Therapeutics Corporation | NYSEAMERICAN |
| Feb 14, 2024 | UMAC | Unusual Machines, Inc. | NYSEAMERICAN |
| Feb 9, 2024 | TBBB | BBB Foods Inc. | NYSE |
| Feb 9, 2024 | HLXB | Helix Acquisition Corp. II | NASDAQ |
| Feb 9, 2024 | TELO | Telomir Pharmaceuticals, Inc. | NASDAQ |
| Feb 9, 2024 | MGX | Metagenomi, Inc. | NASDAQ |
| Feb 8, 2024 | KYTX | Kyverna Therapeutics, Inc. | NASDAQ |
| Feb 8, 2024 | PMNT | Perfect Moment Ltd. | NYSEAMERICAN |
| Feb 7, 2024 | AHR | American Healthcare REIT, Inc. | NYSE |
| Feb 6, 2024 | LEGT | Legato Merger Corp. III | NYSEAMERICAN |
| Feb 2, 2024 | GUTS | Fractyl Health, Inc. | NASDAQ |
| Feb 2, 2024 | ANRO | Alto Neuroscience, Inc. | NYSE |
| Feb 1, 2024 | AS | Amer Sports, Inc. | NYSE |
| Jan 31, 2024 | FBLG | FibroBiologics, Inc. | NASDAQ |
| Jan 26, 2024 | BTSG | BrightSpring Health Services, Inc. | NASDAQ |
| Jan 26, 2024 | AVBP | ArriVent BioPharma, Inc. | NASDAQ |
| Jan 26, 2024 | HAO | Haoxi Health Technology Limited | NASDAQ |
| Jan 25, 2024 | CGON | CG Oncology, Inc. | NASDAQ |
| Jan 25, 2024 | YIBO | Planet Image International Limited | NASDAQ |
| Jan 24, 2024 | SUGP | SU Group Holdings Limited | NASDAQ |
| Jan 24, 2024 | JL | J-Long Group Limited | NASDAQ |
| Jan 19, 2024 | KSPI | Joint Stock Company Kaspi.kz | NASDAQ |
| Jan 19, 2024 | JVSA | JVSPAC Acquisition Corp. | NASDAQ |
| Jan 18, 2024 | PSBD | Palmer Square Capital BDC Inc. | NYSE |
| Jan 18, 2024 | CCTG | CCSC Technology International Holdings Limited | NASDAQ |
| Jan 12, 2024 | SYNX | Silynxcom Ltd. | NYSEAMERICAN |
| Jan 11, 2024 | SDHC | Smith Douglas Homes Corp. | NYSE |
| Jan 9, 2024 | ROMA | Roma Green Finance Limited | NASDAQ |
References 3. Stock Analysis.
References
- https://www.moomoo.com/news/post/31921910/the-12-major-events-that-will-determine-the-direction-of
- https://focus.world-exchanges.org/articles/ipo-trends
- https://stockanalysis.com/ipos/2024/
